Get started
Author

J. Mortimer

422RO A phase II study of patritumab deruxtecan (HER3-DXd) in patients (pts) with metastatic breast cancer (MBC)
2026 · E.P. Hamilton, S. Premji, et al. · ESMO Open · 1
Abstract PS4-10-26: Pretreatment neutrophil-to-lymphocyte ratio is associated with pathologic complete response following neoadjuvant chemo-immunotherapy in early triple-negative breast cancer
2026 · A. LeVee, E. Yang, et al. · Clinical Cancer Research · 1
Abstract PS3-11-04: Adjuvant Ado-Trastuzumab Emtansine (T-DM1) for Older Patients with HER2+ Breast Cancer - Results from the ATOP Study
2026 · R. A. Freedman, H. Heiling, et al. · Clinical Cancer Research · 1
523P Pre-treatment neutrophil-to-lymphocyte ratio and impact on immunotherapy efficacy in patients with metastatic triple-negative breast cancer (mTNBC)
2026 · A. Levee, K. Tsai, et al. · ESMO Open
Abstract PS1-09-07: Central nervous system disease in patients with metaplastic breast cancer receiving antibody drug conjugates: a multi-institutional study
2026 · S. Premji, S. Jacob, et al. · Clinical Cancer Research
Abstract PS4-01-27: Lower Penetrance Germline Fanconi Anemia Variants in Breast Cancer: Opportunities for Expanded Genetic Testing and Therapeutic Targeting in the Updated INSPIRE Study Cohort
2026 · L. Naghi, K. G. Roth, et al. · Clinical Cancer Research
Abstract PS4-07-21: Safety and Clinical Outcomes of Pembrolizumab Standard Dosing Versus Extended-Interval Dosing in Patients with Breast Cancer
2026 · A. LeVee, A. Kordic, et al. · Clinical Cancer Research
Abstract PS1-10-19: Palbociclib, pembrolizumab, and endocrine therapy in HR+/HER2- metastatic breast cancer: Updated results from a phase I/II trial
2026 · A. LeVee, C. Egelston, et al. · Clinical Cancer Research
Abstract PS1-09-18: Efficacy of antibody drug conjugates in patients with advanced metaplastic breast cancer: a multi-institutional retrospective cohort study
2026 · S. Jacob, S. Premji, et al. · Clinical Cancer Research
Abstract PS3-03-18: Guidelines for Breast Cancer Index Test before and after Epic software enhancement
2026 · C. Tran, A. Deshmukh, et al. · Clinical Cancer Research
Works count: 10
Citation count: 3
H-index: 1
I10-index:
Year
Topic
Type